Skip to main content
Clinical Trials/NCT02536482
NCT02536482
Completed
Phase 2

Tolerability to a New Free Amino Acid-based Formula in Children With Cow's Milk Protein Allergy

Edetec Indústria Alimentícia S.A.0 sites15 target enrollmentAugust 2013

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Cow's Milk Allergy
Sponsor
Edetec Indústria Alimentícia S.A.
Enrollment
15
Primary Endpoint
Study to assess the allergic symptoms, using a questionnaire.
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

It is a study to assess the tolerance to a new commercially available infant formula in children affected by Cow's Milk Allergy.

Detailed Description

In the present study, the children will be followed-up during the treatment with the new formula for Cow's Milk Allergy. They will have monthly doctor's appointment, when the weight, height and symptoms will be evaluated, by a questionnaire and a physical examination.

Registry
clinicaltrials.gov
Start Date
August 2013
End Date
June 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Edetec Indústria Alimentícia S.A.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Children with cow's milk allergy

Exclusion Criteria

  • Children without cow's milk allergy

Outcomes

Primary Outcomes

Study to assess the allergic symptoms, using a questionnaire.

Time Frame: 5 months

The allergic symptoms were assessed every month, by using a questionnaire. The parents, during the medical appointment, answered "yes" or "no" according to the presented symptoms: cutaneous (atopic dermatitis and urticaria), gastrointestinal (vomiting, diarrhea constipation and bloody stools ) and respiratory. At the end of the study the children were evaluated if they tolerated the formula, it was observed by the symptoms remission.

Secondary Outcomes

  • Weight assessment, using a digital infant scale(5 months)
  • Height assessment, using an infantometer(5 months)
  • Head circumference, using an infant tape measure(5 months)

Similar Trials